Robert Lorne Hopfner
Director, HYPERION THERAPEUTICS INC.
Companies
- Evommune, Inc.Board member Nov 5, 2025 to now1
- RallybioBoard member Jul 29, 2021 to now2
- Inozyme Pharma, Inc.Board member Jul 23, 2020 to now3
- Vaxcyte, Inc.Board member Jun 11, 2020 to Jun 3, 20214
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Evommune, Inc. EVMN294,502 shares5$1.6M at $5.28Dec 22, 2025
- Inozyme Pharma, Inc.0 shares6Jul 1, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 19, 2025Bought 1,000 shares at $17.35 of Evommune, Inc.5
- Nov 7, 2025Converted 294,502 shares of Evommune, Inc.7
- Nov 7, 2025Converted 1,632,441 shares of Evommune, Inc.7
- Nov 7, 2025Converted 1,441,032 shares of Evommune, Inc.7
- Nov 7, 2025Converted 3,026 shares of Evommune, Inc.7
- Jul 1, 2025U 1,571,741 shares at $4.00 of Inozyme Pharma, Inc.6
- Jul 1, 2025U 2,923,110 shares at $4.00 of Inozyme Pharma, Inc.6
- Aug 1, 2023Bought 714,285 shares at $4.80 of Inozyme Pharma, Inc.8
- Aug 1, 2023Bought 119,048 shares at $4.80 of Inozyme Pharma, Inc.8
- May 12, 2023Bought 228,702 shares at $6.25 of Inozyme Pharma, Inc.9
- May 11, 2023Bought 219,230 shares at $6.48 of Inozyme Pharma, Inc.9
- Mar 29, 2023Bought 344,592 shares at $4.54 of Inozyme Pharma, Inc.10
- Mar 28, 2023Bought 156,766 shares at $4.16 of Inozyme Pharma, Inc.11
- Mar 27, 2023Bought 51,074 shares at $3.70 of Inozyme Pharma, Inc.11
- Apr 19, 2022Bought 1,070,000 shares at $3.69 of Inozyme Pharma, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAREvommune, Inc., Board member
- 2SEC EDGARRallybio, Board member
- 3SEC EDGARInozyme Pharma, Inc., Board member
- 4SEC EDGARVaxcyte, Inc., Board member
- 5
- 6
- 7SEC EDGARForm 4 filed Nov 12, 2025
- 8SEC EDGARForm 4 filed Aug 3, 2023
- 9SEC EDGARForm 4 filed May 15, 2023
- 10SEC EDGARForm 4 filed Mar 30, 2023
- 11SEC EDGARForm 4 filed Mar 29, 2023
- 12SEC EDGARForm 4 filed Apr 20, 2022